Ftse Mib
33.019,00
-0,83%
DAX
19.086,99
-0,32%
S&P 500
5.948,71
0,53%
NASDAQ
18.972,42
0,03%
Bitcoin
98.795,05
0,29%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MannKind Corporation (MNKD) MannKind Corporation (MNKD) Notizie

MannKind Corporation

MNKD
6,90
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:01EDGAR2Form 144 - Report of proposed sale of securities
09/11/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:05EDGAR2Form 8-K - Current report
07/11/202422:02GLOBEMannKind Corporation Reports 2024 Third Quarter Financial..
06/11/202422:04EDGAR2Form 144 - Report of proposed sale of securities
05/11/202422:15GLOBEMannKind to Present at 2024 UBS Healthcare Conference
05/11/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202412:05GLOBEMannKind Successfully Completes Phase 1 Trial of Nintedanib..
31/10/202421:05GLOBEMannKind Corporation to Hold 2024 Third Quarter Financial..
30/9/202412:00GLOBEMore Adults With Type 1 Diabetes Achieved A1C Goal (<7%)..
18/9/202412:15GLOBEMannKind Announces Clearance from PMDA to Initiate Phase 3..
10/9/202422:30GLOBEMannKind to Present at 2024 Cantor Fitzgerald Global..
05/9/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:25EDGAR2Form 144 - Report of proposed sale of securities
30/8/202422:35EDGAR2Form 144 - Report of proposed sale of securities
30/8/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202423:23EDGAR2Form 144 - Report of proposed sale of securities
29/8/202422:15EDGAR2Form 144 - Report of proposed sale of securities
29/8/202422:15EDGAR2Form 144 - Report of proposed sale of securities
27/8/202422:30GLOBEMannKind to Present at Upcoming Conferences
14/8/202414:03EDGAR2Form 8-K - Current report
14/8/202414:00GLOBEKent Kresa to Retire from MannKind’s Board of Directors;..
07/8/202414:05EDGAR2Form 8-K - Current report
07/8/202414:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202414:00GLOBEMannKind Corporation Reports 2024 Second Quarter Financial..
07/8/202411:49IHMARKETNEWSUS Index Futures Rise Amid Earnings Season Optimism, Oil..
31/7/202412:30GLOBEMannKind Launches Educational Website to Raise Awareness of..
30/7/202422:30GLOBEMannKind Corporation to Hold 2024 Second Quarter Financial..
18/7/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:22EDGAR2Form 144 - Report of proposed sale of securities
16/7/202422:19EDGAR2Form 144 - Report of proposed sale of securities
22/6/202414:00GLOBEINHALE-3 Study Reveals Positive Readout in Head-to-Head..
05/6/202412:45GLOBEInhale-3 Study Results to be Presented During a 90-Minute..
30/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202414:45GLOBEMannKind to Establish Boston-Area Research & Development..
22/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:09EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 6,90

La tua Cronologia

NASDAQ
MNKD
MannKind
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network